On the role of phosphatidylethanolamine in the inhibition of activated protein C activity by antiphospholipid antibodies.

M D Smirnov; D T Triplett; P C Comp; N L Esmon; C T Esmon

doi:10.1172/JCI117657

On the role of phosphatidylethanolamine in the inhibition of activated protein C activity by antiphospholipid antibodies.

M D Smirnov, D T Triplett, P C Comp, N L Esmon, and C T Esmon

Published January 1, 1995 - More info

View PDF

Abstract

Phosphatidylethanolamine (PE) is an important membrane component for supporting activated protein C anticoagulant activity but has little influence on prothrombin activation. This difference constitutes a potential mechanism for selective inhibition of the protein C anticoagulant pathway by lupus anticoagulants and/or antiphospholipid antibodies. In this study, we demonstrate that the presence of PE augments lupus anticoagulant activity. In the plasma of some patients with lupus anticoagulants, activated protein C anticoagulant activity is more potently inhibited than prothrombin activation. As a result, in the presence of activated protein C and PE, these patient plasmas clot faster than normal plasma. Patients with minimal lupus anticoagulant activity are identified whose plasma potently inhibits activated protein C anticoagulant activity. This process is also PE dependent. In three patient plasmas, these phenomena are shown to be due to immunoglobulins. The PE requirement in the expression of activated protein C anticoagulant activity and the PE dependence of some antiphospholipid antibodies provide a mechanistic basis for the selective inhibition of the protein C pathway. Inhibition of activated protein C function may be a common mechanism contributing to increased thrombotic risk in certain patients with antiphospholipid antibodies.